Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Hudes

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1997
Genitourinary malignancyN Haas, G R Hudes
Hematology/Oncology Clinics of North America|August 30, 2001
Paclitaxel and docetaxel in prostate cancerC Obasaju, G R Hudes
Seminars in Oncology|April 1, 1988
Phase 1 and 2 studies of trimetrexate administered in combination with fluorouracil to patients with metastatic cancerG R Hudes, R L Comis
American Journal of Clinical Oncology|August 26, 1998
Cisplatin-based chemotherapy for testicular cancer in a patient with spinal muscular atrophy: a case reportD B Sokol, G R Hudes
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1993
Genitourinary malignancyB Giantonio, R F Ozols, G R Hudes
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1994
Genitourinary malignancyG R Hudes, R F Ozols, B Giantonio
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1991
Genitourinary cancerG R Hudes, R F Ozols, R J Schilder
The Prostate|March 1, 1997
Immunohistochemical analysis of beta-tubulin isotypes in human prostate carcinoma and benign prostatic hypertrophyS Ranganathan, H Salazar, C A Benetatos, et al.
Biochimica Et Biophysica Acta|February 25, 1998
Cloning and sequencing of human betaIII-tubulin cDNA: induction of betaIII isotype in human prostate carcinoma cells by acute exposure to antimicrotubule agentsS Ranganathan, D W Dexter, C A Benetatos, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1992
Genitourinary cancerG R Hudes, G Grana, M S Deshields, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1997
Genitourinary malignancyN Haas, G R Hudes
Hematology/Oncology Clinics of North America|August 30, 2001
Paclitaxel and docetaxel in prostate cancerC Obasaju, G R Hudes
Seminars in Oncology|April 1, 1988
Phase 1 and 2 studies of trimetrexate administered in combination with fluorouracil to patients with metastatic cancerG R Hudes, R L Comis
American Journal of Clinical Oncology|August 26, 1998
Cisplatin-based chemotherapy for testicular cancer in a patient with spinal muscular atrophy: a case reportD B Sokol, G R Hudes
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1993
Genitourinary malignancyB Giantonio, R F Ozols, G R Hudes
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1994
Genitourinary malignancyG R Hudes, R F Ozols, B Giantonio
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1991
Genitourinary cancerG R Hudes, R F Ozols, R J Schilder
The Prostate|March 1, 1997
Immunohistochemical analysis of beta-tubulin isotypes in human prostate carcinoma and benign prostatic hypertrophyS Ranganathan, H Salazar, C A Benetatos, et al.
Biochimica Et Biophysica Acta|February 25, 1998
Cloning and sequencing of human betaIII-tubulin cDNA: induction of betaIII isotype in human prostate carcinoma cells by acute exposure to antimicrotubule agentsS Ranganathan, D W Dexter, C A Benetatos, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1992
Genitourinary cancerG R Hudes, G Grana, M S Deshields, et al.
Pageof 5